Your browser doesn't support javascript.
loading
The Phenotypic Spectrum of PRRT2-Associated Paroxysmal Neurologic Disorders in Childhood.
Döring, Jan Henje; Saffari, Afshin; Bast, Thomas; Brockmann, Knut; Ehrhardt, Laura; Fazeli, Walid; Janzarik, Wibke G; Kluger, Gerhard; Muhle, Hiltrud; Møller, Rikke S; Platzer, Konrad; Santos, Joana Larupa; Bache, Iben; Bertsche, Astrid; Bonfert, Michaela; Borggräfe, Ingo; Broser, Philip J; Datta, Alexandre N; Hammer, Trine Bjørg; Hartmann, Hans; Hasse-Wittmer, Anette; Henneke, Marco; Kühne, Hermann; Lemke, Johannes R; Maier, Oliver; Matzker, Eva; Merkenschlager, Andreas; Opp, Joachim; Patzer, Steffi; Rostasy, Kevin; Stark, Birgit; Strzelczyk, Adam; von Stülpnagel, Celina; Weber, Yvonne; Wolff, Markus; Zirn, Birgit; Hoffmann, Georg Friedrich; Kölker, Stefan; Syrbe, Steffen.
Afiliación
  • Döring JH; Division of Paediatric Epileptology, Centre for Paediatric and Adolescent Medicine, University Hospital Heidelberg, 69120 Heidelberg, Germany.
  • Saffari A; Division of Paediatric Neurology and Metabolic Medicince, Centre for Paediatric and Adolescent Medicine, University Hospital, 69120 Heidelberg, Germany.
  • Bast T; Epilepsy Center Kork, Medical Faculty of the University of Freiburg, 77694 Kehl, Germany.
  • Brockmann K; Medical Faculty, University Hospital Freiburg, 79085 Freiburg, Germany.
  • Ehrhardt L; Interdisciplinary Pediatric Center for Children with Developmental Disabilities and Severe Chronic Disorders, Children's Hospital, University Medical Center, 37075 Göttingen, Germany.
  • Fazeli W; Department of Pediatrics, University Medicine Mainz, 55131 Mainz, Germany.
  • Janzarik WG; Pediatric Neurology, Department of Pediatrics, Faculty of Medicine and University Hospital Cologne, University of Cologne, 50937 Cologne, Germany.
  • Kluger G; Institute for Molecular and Behavioral Neuroscience, Faculty of Medicine and University Hospital Cologne, University of Cologne, 50931 Cologne, Germany.
  • Muhle H; Department of Neuropediatrics and Muscle Disorders, Faculty of Medicine, University of Freiburg, 79106 Freiburg, Germany.
  • Møller RS; Clinic for Neuropediatrics and Neurorehabilitation, Epilepsy Center for Children and Adolescents, Schoen Clinic Vogtareuth, 83569 Vogtareuth, Germany.
  • Platzer K; Research Institute for Rehabilitation, Transition and Palliation, PMU Salzburg, 5020 Salzburg, Austria.
  • Santos JL; Department of Neuropediatrics, University Medical Center Schleswig-Holstein, Christian-Albrechts University, 24105 Kiel, Germany.
  • Bache I; Danish Epilepsy Centre, 4293 Dianalund, Denmark.
  • Bertsche A; Institute for Regional Health Research, University of Southern Denmark, 5230 Odense, Denmark.
  • Bonfert M; Institute of Human Genetics, University of Leipzig Medical Center, 04103 Leipzig, Germany.
  • Borggräfe I; Wilhelm Johannsen Centre for Functional Genome Research, Department of Cellular and Molecular Medicine, University of Copenhagen, 2200 Copenhagen, Denmark.
  • Broser PJ; Department of Biomedical Sciences, University of Copenhagen, 2200 Copenhagen, Denmark.
  • Datta AN; Department of Clinical Genetics, Copenhagen University Hospital, Rigshospitalet and Department of Cellular and Molecular Medicine, University of Copenhagen, 2100 Copenhagen, Denmark.
  • Hammer TB; Centre for Paediatric Research, University Hospital for Children and Adolescents, 04103 Leipzig, Germany.
  • Hartmann H; Neuropaediatrics, University Hospital for Children and Adolescents, 18057 Rostock, Germany.
  • Hasse-Wittmer A; Department of Pediatric Neurology, Developmental Medicine and Social Pediatrics, University of Munich, 80337 Munich, Germany.
  • Henneke M; Department of Pediatric Neurology, Developmental Medicine and Social Pediatrics, University of Munich, 80337 Munich, Germany.
  • Kühne H; Epilepsy Center, University of Munich, 80337 Munich, Germany.
  • Lemke JR; Neuropädiatrie, Ostschweizer Kinderspital, 9006 St. Gallen, Switzerland.
  • Maier O; University Children's Hospital Basel, 4031 Basel, Switzerland.
  • Matzker E; Danish Epilepsy Centre, 4293 Dianalund, Denmark.
  • Merkenschlager A; Hannover Medical School, Clinic for Pediatric Kidney, Liver and Metabolic Diseases, 30625 Hannover, Germany.
  • Opp J; Klinikum Traunstein, 83278 Traunstein, Germany.
  • Patzer S; Department of Pediatrics and Adolescent Medicine, University Medical Center, Georg August University, 37075 Göttingen, Germany.
  • Rostasy K; Children's Hospital, 84503 Alt-Neuötting, Germany.
  • Stark B; Institute of Human Genetics, University of Leipzig Medical Center, 04103 Leipzig, Germany.
  • Strzelczyk A; Department of Child Neurology, Children's Hospital, 9006 St. Gallen, Switzerland.
  • von Stülpnagel C; Neuropädiatrie, Carl-Thiem-Klinikum Cottbus, 03048 Cottbus, Germany.
  • Weber Y; Department of Neuropediatrics, University Hospital of Children, 04103 Leipzig, Germany.
  • Wolff M; Children's Hospital, 46047 Oberhausen, Germany.
  • Zirn B; Hospital St. Elizabeth and St. Barbara, 06110 Halle, Germany.
  • Hoffmann GF; Department of Pediatric Neurology, Children's Hospital Datteln, Witten/Herdecke University, 45711 Datteln, Germany.
  • Kölker S; Kepler Universitätsklinikum, 4020 Linz, Austria.
  • Syrbe S; Department of Neurology and Epilepsy Center Frankfurt Rhine-Main, Goethe University Frankfurt, 60528 Frankfurt am Main, Germany.
Biomedicines ; 8(11)2020 Oct 28.
Article en En | MEDLINE | ID: mdl-33126500
ABSTRACT
Pathogenic variants in PRRT2, encoding the proline-rich transmembrane protein 2, have been associated with an evolving spectrum of paroxysmal neurologic disorders. Based on a cohort of children with PRRT2-related infantile epilepsy, this study aimed at delineating the broad clinical spectrum of PRRT2-associated phenotypes in these children and their relatives. Only a few recent larger cohort studies are on record and findings from single reports were not confirmed so far. We collected detailed genetic and phenotypic data of 40 previously unreported patients from 36 families. All patients had benign infantile epilepsy and harbored pathogenic variants in PRRT2 (core cohort). Clinical data of 62 family members were included, comprising a cohort of 102 individuals (extended cohort) with PRRT2-associated neurological disease. Additional phenotypes in the cohort of patients with benign sporadic and familial infantile epilepsy consist of movement disorders with paroxysmal kinesigenic dyskinesia in six patients, infantile-onset movement disorders in 2 of 40 individuals, and episodic ataxia after mild head trauma in one girl with bi-allelic variants in PRRT2. The same girl displayed a focal cortical dysplasia upon brain imaging. Familial hemiplegic migraine and migraine with aura were reported in nine families. A single individual developed epilepsy with continuous spikes and waves during sleep. In addition to known variants, we report the novel variant c.843G>T, p.(Trp281Cys) that co-segregated with benign infantile epilepsy and migraine in one family. Our study highlights the variability of clinical presentations of patients harboring pathogenic PRRT2 variants and expands the associated phenotypic spectrum.
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Observational_studies / Risk_factors_studies Idioma: En Revista: Biomedicines Año: 2020 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Observational_studies / Risk_factors_studies Idioma: En Revista: Biomedicines Año: 2020 Tipo del documento: Article País de afiliación: Alemania